Biosimilars in developed economies: Overview, status, and regulatory considerations
This article summarizes the main regulatory requirements for approval of biosimilars in Europe, United States, Japan, Canada, and South Korea. An overview on current biosimilars status and market in the aforesaid countries has also been included.Graphical abstract
Source: Regulatory Toxicology and Pharmacology - Category: Toxicology Source Type: research
More News: Canada Health | Drugs & Pharmacology | Healthcare Costs | Hormones | Japan Health | South Korea Health | Toxicology | USA Health | Vaccines